表紙
市場調查報告書

醫療圖像的全球市場:季度調查 (2019年第一季)

Medical Imaging Industry Quarterly Tracker, Q2 2019

出版商 Frost & Sullivan 商品編碼 913144
出版日期 內容資訊 英文 73 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫療圖像的全球市場:季度調查 (2019年第一季) Medical Imaging Industry Quarterly Tracker, Q2 2019
出版日期: 2019年11月21日內容資訊: 英文 73 Pages
簡介

醫療圖像、資訊學產業新的產品和解決方案不斷投入市場中,急速發展。

本報告提供以季度為基礎的全球醫療圖像市場調查,臨床部門的主要趨勢,新產品、解決方案的市場展開、引進情形,新產品的功能、能力,FDA、CE核准趨勢,FDA、CE回收趨勢,相關法律、償付政策等趨勢,M&A、企業間的聯盟等趨勢,關注的活動等彙整資料。

摘要整理

競爭環境

  • 長期事業契約
  • 新產品的市場投入
  • 企業亮點
  • 事業合作
  • FDA核准
  • CE核准
  • FDA回收

政策、法律規章

臨床趨勢

活動亮點

總論

  • 總論
  • 免責聲明

附錄

關於FROST & SULLIVAN

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MF08-50

Quarterly Edition of Trends in Medical Imaging and Informatics, Covering Competition, Policy, Regulatory, and Clinical Areas

The medical imaging and informatics industry is evolving rapidly, and new products and solutions are launched every other day. As the reimbursement environment is transitioning from fee-for-service to value-based payment, vendors' business models and value propositions are undergoing drastic changes. New evidence regarding the use of certain techniques in imaging is influencing changes in the standard of care. On a macro level, the government's policies on reimbursement and regulations tend to impact the performance of industry participants, if their internal teams delay the calibration of the strategic actions needed to thrive in this new environment.

To help its clients address challenges in an intensely competitive environment, Frost & Sullivan has introduced the Medical Imaging and Informatics Quarterly Insights tracker that will monitor market factors and significant events and qualitatively assess their impact on the industry; this will cover the diagnostic imaging, image-guided therapies, and imaging informatics segments.

Research Scope:

The scope of this deliverable covers the following segments:

Clinical Trends

  • Disruptive trends impacting the current ‘gold standard'
  • Trends indicating the clinical adoption of new solutions /products
  • Important announcements from associations, such as RSNA, ESR, ACR, and ACC

Competition

  • New product launches and capabilities
  • Mergers & acquisitions
  • FDA & CE approvals
  • Major FDA & CE recalls/warnings

Policy and Regulations

  • Region-specific introduction of new regulatory approvals
  • Reimbursement achievements or setbacks

Event Highlights

  • Major events highlights in the quarter covering the major themes, derived by studying the messaging and communications, product launches, and product promotions at the event

Table of Contents

Executive Summary

  • Executive Summary
  • Research Scope

Competitive Analysis

  • Long-term Business Contracts-Customer Acquisitions
  • Long-term Business Contracts-Customer Acquisitions (continued)
  • Long-term Business Contracts-Customer Acquisitions (continued)
  • New Launches and Upgrades
  • New Launches and Upgrades (continued)
  • Mergers and Acquisitions
  • Mergers and Acquisitions (continued)
  • Strategic Collaborations
  • FDA Approvals for Products of Top Tier Participants (April-June 2019)
  • FDA Approvals for Products of Other Participants (April-June 2019)
  • Notable CE Approvals
  • FDA Recalls
  • FDA Recalls (continued)
  • FDA Recalls (continued)
  • FDA Recalls (continued)
  • FDA Recalls (continued)
  • FDA Recalls (continued)
  • Analyst Perspective

Policies and Regulations

  • 1. Proposed Electronic Health Information Interoperability Rules
  • 2. USFDA's Final Guidelines for Regulatory Standards for Medical Imaging Equipment
  • 3. CMS Mandates CDS Software for Ordering Medical Imaging Decisions
  • 4. Guidelines for Marketing Clearance of Diagnostic Ultrasound Systems and Transducers
  • 5. Technical Considerations and Imaging Techniques for Valvular Regurgitation
  • 6. Draft Premarket Recommendations for Manufacturers on Quantitative Medical Imaging
  • 7. Royal College of Radiologists Reports Shortage of Radiologists in UK
  • 8. UK Royal College of Radiologists Issues Guidance On The Administration of Gadolinium-based Contrast Agents
  • 9. NMPA's New Guidelines for the Medical Devices Industry Standards
  • 10. Technical Guideline on Artificial Intelligence Software, 2019
  • 11. Tightened Regulations for Medical Imaging Devices In India
  • 12. Public-Private Partnership for Radiology and Medical Imaging Services
  • 13. Diagnostic Imaging and Radiation Oncology Practices Eligibility for Medicare Benefits

Clinical Trends

  • 1. Ga-68 PSMA PET/CT, the Modality of Choice for Staging of Prostate Cancer
  • 2. Discovery of Higher Incidence in Women during China's Lung Cancer CT Screening
  • 3. Better Patient Outcomes with Intravascular Ultrasound
  • 4. Coronary Angiography after Cardiac Arrest without ST-Segment Elevation
  • 5. Magnetic Resonance Perfusion Versus Fractional Flow Reserve in Stable Angina
  • 6. Accuracy of Whole-body MRI in Lung and Colon Cancers
  • 7. American Medical Association (AMA) Approval of Four New CPT Codes for 3D Printing
  • 8. Tripling of Digital Breast Tomosynthesis (DBT) Adoption in 3 Years
  • 9. Release of the American Society of Breast Surgeons (ASBrS) Position Statement on Risk-based Breast Screening and DBT
  • 10. Electromechanical Wave Imaging Proving Superior to Electrocardiogram (ECG) in Mapping Cardiac Arrhythmias

Events

  • Trending Themes at the 2018 AIUM Convention, April 2019
  • Trending Themes at the ESTRO 38, April 2019
  • Trending Themes at the ISMRM 27th Annual Meeting & Exhibition, May 2019
  • Trending Themes at the SIIM19 Annual Meeting, June 2019

Conclusion

  • Conclusion

Appendix

  • List of Exhibits
  • List of Exhibits (continued)
  • List of Abbreviations
  • Legal Disclaimer

The Frost & Sullivan Story

  • The Frost & Sullivan Story
  • Value Proposition: Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360º Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top